Tag: NASDAQ:FURX

  • Morning Top News: Facebook Inc (NASDAQ:FB), Vodafone Group Plc (NASDAQ:VOD), POZEN Inc. (NASDAQ:POZN), Furiex Pharmaceuticals Inc (NASDAQ:FURX)

    Facebook (NASDAQ:FB)‘s stock had its “buy” rating reaffirmed by research analysts at Bank of America in a report released on Thursday, AR Network reports. They currently have a $84.00 target price on the stock, up from their previous target price of $82.00. Bank of America’s price target indicates a potential upside of 45.56% from the stock’s previous close. Facebook Inc (NASDAQ:FB) stock opened today at $58.05 and is currently trading at $56.86. The stock showed a negative weekly performance of -2.09%.

    With the recent signing of a five year global agreement with International Telematics Limited (ITL), Vodafone New Zealand has reached over one million Machine-to-Machine (M2M) connections. For the third year in a row, Vodafone has also topped the rankings for its M2M services in Analysys Mason’s independent M2M annual scorecard. Vodafone Group Plc (ADR) (NASDAQ:VOD) stock opened at $36.68, in current trading session and currently is at $36.61, by loosing -0.16%.The 52 week range of $35.01-$72.55. Company’s market capitalization is $96.79 billion.

    POZEN Inc. (Nasdaq: POZN) announced that their drug candidates PA8140/PA32540 (aspirin and omeprazole) delayed release tablets have received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA). A CRL is issued by the FDA when the review of the file is completed and questions remain that preclude the approval of the new drug application (NDA) in its current form. POZEN Inc. (NASDAQ:POZN) stock is currently trading at $7.79.The EPS of the stock is -0.55. Company’s market capitalization is $240.09 million.

    Forest Laboratories Inc (FRX.N) said it would buy Furiex Pharmaceuticals Inc (NASDAQ:FURX) for up to $1.46 billion including milestone payments to access Furiex’s promising treatment for irritable bowel syndrome. This is the latest in a series of healthcare deals and offers that have been structured to either gain scale or build up expertise in specific disease areas. Furiex Pharmaceuticals Inc (NASDAQ:FURX) stock opened the session at $103.10, and now is at $102.90. The 52 week range of the FURX stock remained $32.01-$121.97 and the day range was $102.41-$103.88.